2 results
Approved WMOCompleted
To compare the efficacy and safety of lenalidomide versus placebo maintenance therapy (standard care).
Approved WMOCompleted
Investigate the effects of 7 (+-1) days of of mono- and combination therapy with the SGLT2 inhibitor empagliflozin (10 mg QD) and RAS inhibitor losartan (50 mg QD) on renal hemodynamics, (glomerular filtration rate (GFR) / effective renal plasma…